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Abstract
The notion of “reverse innovation”–that some insights from low-income countries might offer transferable lessons
for wealthier contexts--is increasingly common in the global health and business strategy literature. Yet the
perspectives of researchers and policymakers in settings where these innovations are developed have been largely
absent from the discussion to date. In this Commentary, we present examples of programmatic, technological, and
research-based innovations from Rwanda, and offer reflections on how the global health community might
leverage innovative partnerships for shared learning and improved health outcomes in all countries.
Introduction
In the early 2000s, citizens across Africa were mobiliz-
ing for access to the lifesaving antiretroviral therapy
( A R T )t h a th a dl e dt od r a m a t i cd e c l i n e si nA I D Sm o r -
tality in the United States and Europe. Though the
AIDS pandemic was crippling economies across the
continent and countries faced the real prospect of los-
ing an entire generation, many in public health placed
effective treatment in opposition to prevention. Lead-
ing medical journals published modeling studies with
confident assertions that flatly stated, for example, that
“prevention is at least 28 times more cost-effective than
ART [in Africa]” [1]; at least one influential voice in de-
velopment circles argued that Africans living with HIV
could never adhere to therapy because they “don’t
know what Western time is [2].” These assertions,
though un-buttressed by data, were typical of attitudes
widespread among opinion makers in public health and
within institutions charged with promoting health and
economic development.
A decade later, in the wake of unprecedented inter-
national solidarity and funding, more than 7.1 million
women, men, and children are receiving ART in Africa
[3]. New studies have shown ART to reduce the likeli-
hood of HIV transmission by up to 96% [4], and pooled
analyses have demonstrated that African patients exhibit sig-
nificantly higher adherence to treatment than their North
American counterparts [5]. In Rwanda, AIDS-related deaths
have declined by 83.1% since 2000—even more steeply than
the comparable post-ART period after 1996 in Europe and
North America [6]. An estimated 83.3% percent of HIV-
positive adults on ART in Rwanda are virally suppressed [7],
and community-based approaches to HIV care delivery re-
fined in Rwanda and Haiti are now being implemented in
the United States [8].
Pathologies from AIDS to cancer do not discriminate
along lines of nationality, yet the notion that poor coun-
tries’ experiences addressing such conditions might
offer lessons for settings rich and poor alike has only re-
cently been recognized in the medical literature [9-12].
Most discussion to date has termed such exchanges “re-
verse innovation,” [ 8 ]t h o u g hs o m eh a v ea r g u e df o ra
more explicitly bi-directional framework that recognizes
best practices regardless of where they emerge [13-15].
Towards a learning health system
While numerous gaps still exist (especially with regards
to human resources), Rwanda has made significant pro-
gress in recent years towards an enabling regulatory
and academic environment for evidence-based health
* Correspondence: agnes_binagwaho@hms.harvard.edu
1Ministry of Health of Rwanda, Kigali, Rwanda
2Harvard Medical School, Boston, MA, USA
Full list of author information is available at the end of the article
© 2013 Binagwaho et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Binagwaho et al. Globalization and Health 2013, 9:37
http://www.globalizationandhealth.com/content/9/1/37innovation [16]. Most recently, the Rwandan govern-
ment adopted a national Health Sector Research Policy
to guide work from clinical trials to operational and so-
cial science research [17]. Research based on local
needs has been an engine of improvement in the health
sector, and has contributed to Rwanda’s likely achieve-
ment of the health-related Millennium Development
goals [18,19].
We contend that Rwanda’s linkage of equitable health
care delivery to research has catalyzed health innovation
through three specific mechanisms. First, major health
financing and care delivery initiatives have been evalu-
ated through carefully planned phased-rollouts and in-
vestigational designs that students of innovation call
“disciplined experiments” [20] (Table 1). Such ap-
proaches can be challenging to plan and controversial
when they inevitably threaten conventional ways of
doing things, but they are invaluable for learning and
improving.
A second and more routine approach to studying and dis-
seminating innovations has been individual policymakers’
commitment to (and their institutions’ support for) retro-
spectively evaluating novel strategies to improve service de-
livery. Countries across Africa—and the world—face many
of the same challenges, from treatment of multidrug-
resistant tuberculosis patients co-infected with HIV to deliv-
ery of three doses of the human papillomavirus vaccine to
adolescent girls. The innovations require rigorous monitor-
ing and evaluation to objectively report their effect on the
health system. Publication of Rwanda’s experiences in inter-
national peer-reviewed journals has shared solutions that
worked in Rwanda with researchers across continents and
contexts, and has sparked a nascent culture of innovation
and reflection in the health sector (Table 2).
Finally, Rwanda has sought to provide a supportive en-
vironment for the development of new health tools
designed specifically for the rural African context (Table 3).
When distributed equitably, new technologies can acceler-
ate health gains and narrow inequalities [15]. Public sector
authorities encourage local manufacturing of devices de-
veloped or studied in Rwanda, and the World Bank re-
cently ranked Rwanda 8
th of 185 countries for ease of
starting a business and the 2
nd most improved business re-
former since 2005 [40]. Although much work remains to
fabricate the majority of medical innovations in-country,
the breadth of available processes and increasing attention
to international quality standards are promising.
Mutual capacity building
New technologies and better ways of organizing services
will matter little to patients, however, if there is no one to
deliver them. As a result of the 1994 genocide, Rwanda
faces one of the world’s most severe human resources for
health shortages. International partnerships, whether with
non-governmental organizations or universities, are man-
dated to prioritize the transfer of capacity; over the past
decade, however, it has become increasingly clear that the
flow of knowledge goes—and, we argue, must go—the
other way, too.
As one example, eight years of collaboration between
the Rwandan Ministry of Health, the non-governmental
organization Partners In Health, Harvard Medical School,
and the Brigham and Women’s Hospital in Boston has
contributed to the launch of a new discipline of global
health delivery [46]. With courses now taught in both
Boston and rural Rwanda, and with masters-level pro-
grams launching in both settings, stakeholders in both
nations have built capacity among students, clinicians,
and faculty while accelerating pedagogical innovation [47].
Rwanda’s Butaro District Hospital, built through a govern-
mental partnership with MASS Design Group, Partners In
Health, and the Clinton Health Access Initiative, is the site
of design and infection control innovations that are being
studied by architects as a model for contextually respon-
sive, impact-oriented design, which could inform the way
facilities are built to meet real needs globally, in both poor
and wealthy nations [48,49].
On a much larger scale, Rwanda launched its Human
Resources for Health Program in 2012, partnering with
16 American academic medical centers to increase the
quantity and skill level of Rwanda’s physicians, nurses,
midwives, and health managers, while diversifying the
health workforce’s skill mix over seven years [50]. Each
participating American faculty member is contracted for
a twelve-month period and “twinned” with a Rwandan
counterpart; the resulting individual and institutional
partnerships will bear fruit well beyond the program’s
end by creating cycles of innovation and learning in both
directions. Most importantly, clinical practice and health
systems are being enhanced in transformative ways in
some of Rwanda’s most remote districts [51].
The future of innovation in global health
As we have previously observed, for too long the world
waited as “pathogens like HIV jet[ted] around the world”
while “their remedies remain[ed] stuck in customs [52].”
For many individual diseases, this situation is changing rap-
idly for the better; yet the global trade in ideas and
Table 1 “Disciplined experiments” to learn from,
improve, and scale innovations in care delivery
￿ Community-based health insurance scale-up [21,22]
￿ Performance-based financing for maternal and child health
services [23] and HIV care delivery [24]
￿ Accompaniment for HIV patients by community health
workers [25,26]
￿ Comprehensive quality improvement and integrated platforms of
community-based district health services [27]
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ing editors of and contributors to the global scientific com-
mons are well positioned to disrupt the status quo and
foster new channels of South-North and South-South com-
munication through the medical literature, where the per-
spectives of researchers and policymakers from low-income
settings are currently few and far between.
We therefore eagerly welcome Globalization and
Health’s new series on innovation in global health sys-
tems as an encouraging start [12]. But what might it
take to catalyze a truly equal dialogue aimed at shared
learning across borders and across historical gradients
of inequality? Based on our experiences working to-
gether in Rwanda’s health sector, we suggest five key
ingredients below:
1. How will it benefit the poorest?—This fundamental
question should be at the heart of all global health
partnerships, whether for research, policy, or service
delivery, and it should fuel conversations between
implementing partners, funding institutions, IRBs,
and policymakers.
2. Asking questions that matter to patients—Global
health research agendas should be derived in part
from patients’ notions of what is most at stake—this
means listening [53]. The provision of transportation
fare support for HIV patients, for instance, might
seem outside the realm of a traditional research
partnership. Yet given the average family income in
rural Africa, a monthly round-trip bus ticket to a
far-away clinic poses a similar proportional financial
burden as would a business-class airplane ticket
from Boston to Los Angeles for a middle-class
American family.
3. Experimentation across contexts—Learning
collaboratives, both between diverse partners in one
setting [54] and between international collaborators
[55], can be a powerful innovation tool when
combined with “disciplined experimentation [8].”
Timely publication of both positive and negative
findings that result is a must, and requires journals
and their editors to prize such experiences.
4. Open access for open dialogue—When accessing a
single journal article can cost an African physician
in the public sector two days’ salary (and what of the
health journalist, or nurse?), even the best
innovations will fail to make an impact. Open access
journals are essential for harnessing the benefits of
shared innovation.
5. Reciprocity and respect—International health
research has long been semi-colonial and extractive
[56]; global health equity also means intellectual
partnership with the goal of equity. True partnership
in international research projects means having local
co-principal investigators and equal contributions to
and representation on scientific articles. Further, not
all “reverse innovations” stem from economic
scarcity; scientists and program managers in poor
Table 2 Rigorous monitoring and evaluation of health systems innovations
￿“ Diagonal approach” to HIV treatment rollout focused on health systems strengthening [28]
￿ Task-shifting of HIV care and treatment from physicians to nurses [29] and community health workers [30]
￿ Provision of food and transportation assistance to support adherence among multidrug-resistant tuberculosis patients [31]
￿ School-based vaccination and community health worker tracing of out-of-school girls for Africa’s first human papillomavirus vaccination
program [32]
￿ Leveraging local expertise to increase enrollment in the health insurance system [33]
￿ Mobile phone- and internet-based monitoring, evaluation, and reporting system for HIV diagnosis, care, and treatment [34,35]
￿ The “Single Project Implementation Unit” to coordinate donor funds, and financial mechanisms for the provision of technical assistance to
other low-income countries [36]
￿ A “Mentoring and Enhanced Supervision of Health Centers” strategy to improve the quality of care delivered by nurse-providers at rural health
centers [37]
￿ Intervention coverage and quality improvement monitoring of national malaria [38] and integrated TB-HIV programs [39]
￿ Collaborations with traditional healers to explore possible therapeutic efficacy of herbal medicines [16]
Table 3 Supportive environment for context-specific health technology development
￿ The “Byumba fix,” a low-cost, locally manufactured external fixator for setting fractures developed in the aftermath of the 1994 genocide [41]
￿ Open MRS, a customizable open-source electronic medical record system [42]
￿ PrePex, a nonsurgical male circumcision device for HIV prevention [43]
￿ The Wound Pump, a low-cost negative pressure wound pump requiring no electricity [44]
￿ mChip, a low-cost mobile phone-based HIV diagnostic device [45]
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resources just like their rich-country counterparts,
and partners on both sides have lessons to share.
Looking forward, we believe that linking humility and
bold vision to scientific rigor is the surest route to value
and equity in global health. Some of the leading challenges
facing health systems around the world in the twenty-first
century may not be amenable to innovations derived from
other contexts, but many are: all countries face the task of
providing universal access to high quality, high value care.
For the still-nascent field of global health to advance, we
must embrace two-way learning; after all, we live in one
world, not three, and the communities where this journal’s
online readers live are as surely on the globe as are Kigali
or Boston [57].
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